Schroder Investment Management Group
RCUS icon

Schroder Investment Management Group’s Arcus Biosciences RCUS Stock Holding History

Schroder Investment Management Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,485
Closed -$315K – 1237
2023
Q2 		$315K Sell
15,485
-249,579
-94% -$4.75M ﹤0.01% 1160
2023
Q1 		$4.83M Buy
265,064
+148,932
+128% +$2.85M 0.01% 791
2022
Q4 		$2.4M Sell
116,132
-1,410
-1% -$38.8K ﹤0.01% 910
2022
Q3 		$3.08M Buy
117,542
+88,849
+310% +$2.35M 0.01% 863
2022
Q2 		$700K Buy
+28,693
New +$703K ﹤0.01% 1128

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Schroder Investment Management Group's RCUS Position: Q3 2023 in Review

Schroder Investment Management Group sold out of Arcus Biosciences (RCUS) in Q3 2023, closing a stake of 15,485 shares — an estimated $315K sold.

Schroder Investment Management Group first reported a position in RCUS in Q2 2022 and held it in 5 quarters. The position peaked at $4.83M in Q1 2023. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2023.

  • Schroder Investment Management Group reported no remaining Arcus Biosciences position as of Q3 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 15,485 Arcus Biosciences shares in Q3 2023, an estimated $315K.
  • Schroder Investment Management Group first reported a position in Arcus Biosciences in Q2 2022 and held it in 5 quarters.
  • Schroder Investment Management Group's Arcus Biosciences position peaked at $4.83M in Q1 2023.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2023.

Based on Schroder Investment Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.